Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Recordati Industria Chimica e Farmaceutica SPA ( (IT:REC) ) has issued an announcement.
Recordati S.p.A. announced an update on its share buyback program, which was initiated to support stock options and performance share plans for the company’s management. From June 30 to July 4, 2025, the company purchased 80,423 ordinary shares at an average price of €53.5657, increasing its total holdings to 3,623,213 shares, representing 1.733% of its share capital. This strategic move aims to strengthen the company’s market position and provide incentives for its management team.
The most recent analyst rating on (IT:REC) stock is a Hold with a EUR51.00 price target. To see the full list of analyst forecasts on Recordati Industria Chimica e Farmaceutica SPA stock, see the IT:REC Stock Forecast page.
More about Recordati Industria Chimica e Farmaceutica SPA
Recordati is an international pharmaceutical group listed on the Italian Stock Exchange, with origins in a family pharmacy in Northern Italy in the 1920s. The company provides therapeutic options in specialty and general medicine, as well as in rare diseases, and operates in about 150 countries across EMEA, Americas, and APAC regions with over 4,580 employees.
Average Trading Volume: 314,367
Technical Sentiment Signal: Strong Buy
Current Market Cap: €11.09B
Learn more about REC stock on TipRanks’ Stock Analysis page.